Back to announcement
20260715_KLBF_Laporan Pengalihan Saham Hasil Buy Back_32112313_lamp1.pdf
Other Text extracted KLBFSource file signed link, expires in 15 minutes
Extracted text 3
Page 1
No. : 056/CSEC-KF/VIII-2026 Jakarta, 15 Juli 2026 / July 15, 2026 Kepada Yth. To. Kepala Eksekutif Pengawas Pasar Modal, Executive Head of Capital Market, Derivative Keuangan Derivatif dan Bursa Karbon Finance and Carbon Exchange Supervision Otoritas Jasa Keuangan (OJK) Financial Services Authority (OJK) Gedung Soemitro Djojohadikusumo Gedung Soemitro Djojohadikusumo Jl. Lapangan Banteng Timur No. 2-4 Jl. Lapangan Banteng Timur No. 2-4 Jakarta 10710 Jakarta 10710 Perihal : Laporan Hasil Pelaksanaan Pembelian Regarding : Report on the Completion of Shares Kembali Saham dan Laporan Perkembangan Buyback and Progress Report on the Transfer of Pengalihan Saham Hasil Pembelian Kembali Treasury Shares Dengan hormat, Dear Sir/Madam, Merujuk pada (i) Keterbukaan Informasi Rencana With reference to (i) the Disclosure of Information on Pembelian Kembali Saham PT Kalbe Farma Tbk the Plan for Shares Buyback of PT Kalbe Farma Tbk (“Perseroan”); (ii) Peraturan Otoritas Jasa (the “Company”); (ii) the Financial Services Keuangan (“POJK”) No. 29 Tahun 2023 tentang Authority Regulation (the “POJK”) No. 29 of 2023 Pembelian Kembali Saham yang Dikeluarkan oleh regarding Shares Buyback Issued by Public Perusahaan Terbuka; (iii) POJK No. 13 Tahun 2023 Companies; and (iii) POJK Regulation No. 13 of tentang Kebijakan Dalam Menjaga Kinerja Dan 2023 regarding Policies in Maintaining Capital Stabilitas Pasar Modal Pada Kondisi Pasar Yang Market Performance and Stability Under Berfluktuasi Secara Signifikan, Perseroan dengan Significantly Fluctuating Market Conditions, the ini menyampaikan Laporan Hasil Pelaksanaan Company hereby submits the Report on the Pembelian Kembali Saham dan Laporan Completion of Shares Buyback and Progress Report Perkembangan Pengalihan Saham Hasil Pembelian on the Transfer of Treasury Shares conducted from Kembali yang dilakukan sejak tanggal 1 Januari January 1, 2026, to June 30, 2026, as attached. 2026 s.d. 30 Juni 2026 sebagaimana terlampir. Demikian kami sampaikan dan terima kasih atas Thank you for your kind attention. perhatiannya. Hormat kami, / Best regards¸ PT Kalbe Farma Tbk Maria Teresa Fabiola Corporate Secretary PT. KALBE FARMA Tbk. Head Office : Gedung KALBE, Jl. Let. Jend. Suprapto Kav. 4, Jakarta 10510, P.O. Box 3105 JAK, Jakarta, Indonesia. Tel. (021) 42873888 - 89 Fax. (021) 42873680 Factory : Kawasan Industri Delta Silicon, Jl. M. H. Thamrin Blok A3 – 1, Lippo Cikarang, Bekasi 17550, P.O. Box 371 Bekasi 17037. Indonesia. Tel. (021) 89907333 Fax. (021) 8972874 Info@kalbe.co.id
Page 2
Laporan Hasil Pembelian Kembali Saham / Report on the Implementation of Shares Buyback
PT KALBE FARMA TBK
Harga rata- Persentase jumlah nominal saham yang dibeli
Jumlah Saham rata dari seluruh jumlah nominal saham yang akan
Sisa Biaya Pembelian Kembali
Tanggal Transaksi / yang Dibeli / pembelian dibeli sesuai RUPS* / Percentage of the total
No. Saham (Rp) / Outstanding Shares
Transaction Date Total Shares (Rp) / Average nominal value of shares repurchased out of the
Buyback Cost (IDR)
Purchased purchase price total nominal value of shares approved for
(IDR) buyback by the GMS*
1 1 – 31 July 2025 25.725.800 1.512 16% 211.097.007.500
2 01 – 31 August 2025 28.100.000 1.417 16% 171.227.214.000
3 1 – 30 September 2025 16.773.000 1.179 8% 230.232.280.000
4 1 – 31 October 2025 25.071.500 1.167 12% 201.284.628.000
5 1 – 30 November 2025 - - 0% 201.284.628.000
6 1 – 31 December 2025 4.350.000 1.140 2% 196.336.030.500
7 1 – 31 January 2026 28.193.500 1.224 13,8% 215.483.770.000
8 1 – 28 February 2026 - - 0% 215.483.770.000
9 1 – 31 March 2026 9.475.000 1.000 3,8% 206.011.850.500
10 1 – 30 April 2026 - - 0% 206.011.850.500
11 1 – 31 Mei 2026 - - 0% 206.011.850.500
12 1 – 30 June 2026 - - 0% 206.011.850.500
(*) Buyback dalam keadaan pasar berfluktuatif sesuai POJK No. 13 Tahun 2023 dan Keterbukaan Informasi Perseroan tanggal 2 Mei 2025, 2 September 2025, 12 Desember 2025,
dan 1 April 2026. / (*) Buyback during market fluctuation pursuant to POJK No. 13 of 2023 and the Company’s Information Disclosures dated May 2, 2025, September 2, 2025, December
12, 2025, and April 1, 2026.
Hormat kami, / Best regards¸
PT Kalbe Farma Tbk
Maria Teresa Fabiola
Corporate Secretary
PT. KALBE FARMA Tbk.
Head Office : Gedung KALBE, Jl. Let. Jend. Suprapto Kav. 4, Jakarta 10510, P.O. Box 3105 JAK, Jakarta, Indonesia. Tel. (021) 42873888 - 89 Fax. (021) 42873680
Factory : Kawasan Industri Delta Silicon, Jl. M. H. Thamrin Blok A3 – 1, Lippo Cikarang, Bekasi 17550, P.O. Box 371 Bekasi 17037. Indonesia.
Tel. (021) 89907333 Fax. (021) 8972874 Info@kalbe.co.id
Page 3
Laporan Perkembangan Pengalihan Saham Hasil Pembelian Kembali Saham / Progress Report on the Transfer of Shares Acquired from Share Buyback
PT KALBE FARMA TBK
Tanggal
Harga Rata Tanggal RUPS
Pelaksanaan Jumlah Saham
Rata atau Jumlah
RUPS Tanggal yang Wajib Harga Sisa Saham yang
Pembelian Keterbukaan Tanggal Saham yang
Pembelian Selesainya Dialihkan Pengalihan Jumlah Saham yang Wajib Dialihkan
Kembali Informasi Pengalihan Dialihkan Cara Pengalihan Kembali
Kembali Pembelian Kembali Kembali / Saham (Rp) Telah Dialihkan Kembali / Remaining
Saham (Rp) Pengalihan Saham / Kembali / Saham / Method of
Saham / Date of Saham / Number of / Shares Kembali / Number of Number of Shares
/ Average Saham / GMS Share Number of Shares Transfer
GMS Completion Date of Shares Subject Transfer Shares Transferred Subject to Mandatory
Shares Date or Share Transfer Date Shares
Implementation the Shares Buyback to Mandatory Price (IDR) Transfer
Buyback Transfer Transferred
of Shares Transfer
Price (IDR) Disclosure Date
Buyback
09 Feb 2022 - 08 Ditarik kembali dengan
09 Feb 2022 1.609
May 2022 cara pengurangan modal
ditempatkan dan disetor
617.305.700 09 May 2025 20 Apr 2025 61.730.570 - Perseroan / Withdrawn by 61.730.570 555.575.130
20 May 2022 - 19
20 May 2022 1.633 way of reduction of the
Aug 2022
Company's issued and
paid-up capital
16 May 2024 - 15
05 Apr 2024 1.319 757.972.500 - - - - - - 757.972.500
May 2025
05 May 2025 - 04
02 May 2025* 1.503 167.120.800 - - - - - - 167.120.800
Aug 2025
04 Sep 2025 - 03
02 Sep 2025* 1.166 46.194.500 - - - - - - 46.194.500
Dec 2025
16 Dec 2025 - 15
12 Dec 2025* 1.178 37.688.500 - - - - - - 37.688.500
Mar 2026
2 Apr 2026 - 2 Jul
1 Apr 2026*/** - - - - - - - - -
2026
(*) Buyback dalam keadaan pasar berfluktuatif sesuai POJK No. 13 Tahun 2023 dan Keterbukaan Informasi Perseroan tanggal 2 Mei 2025, 2 September 2025, 12 Desember 2025, dan 1 April 2026. / (*)
Buyback during market fluctuation pursuant to POJK No. 13 of 2023 and the Company’s Information Disclosures dated May 2, 2025, September 2, 2025, December 12, 2025, and April 1, 2026.
(**) Belum terdapat realisasi Pembelian Kembali Saham dalam periode tersebut. / (**) There has been no realization of Share Buyback during the period.
Hormat kami, / Best regards¸
PT Kalbe Farma Tbk
Maria Teresa Fabiola
Corporate Secretary
PT. KALBE FARMA Tbk.
Head Office : Gedung KALBE, Jl. Let. Jend. Suprapto Kav. 4, Jakarta 10510, P.O. Box 3105 JAK, Jakarta, Indonesia. Tel. (021) 42873888 - 89 Fax. (021) 42873680
Factory : Kawasan Industri Delta Silicon, Jl. M. H. Thamrin Blok A3 – 1, Lippo Cikarang, Bekasi 17550, P.O. Box 371 Bekasi 17037. Indonesia.
Tel. (021) 89907333 Fax. (021) 8972874 Info@kalbe.co.id
Names mentioned 6 people and organisations named in the text · linked when the evidence is strong
unresolved
org
Financial Services Authority
p.1
unresolved
person
Maria Teresa Fabiola
· Corporate Secretary
p.1 ×3
unresolved
person
H. Thamrin
p.1 ×3
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.